Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021-23: How do we switch to a life course approach?

Autor: Bak J; Immunization, Vaccine Preventable Disease and Polio Transition Unit, Department of Communicable Diseases and Universal Health Coverage, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: bakj@who.int., Hasan Q; Immunization, Vaccine Preventable Disease and Polio Transition Unit, Department of Communicable Diseases and Universal Health Coverage, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: hasanq@who.int., Kissa J; Immunization, Vaccine Preventable Disease and Polio Transition Unit, Department of Communicable Diseases and Universal Health Coverage, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: kissaj@who.int., Mere MO; Immunization, Vaccine Preventable Disease and Polio Transition Unit, Department of Communicable Diseases and Universal Health Coverage, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: mereo@who.int., Samhouri D; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: samhourid@who.int., Gillespie A; United Nations International Children's Emergency Fund for Middle East and North Africa Regional Office, Amman, Jordan. Electronic address: agillespie@unicef.org., Aynsley TR; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: aynsleyt@who.int., Abubakar A; WHO Health Emergencies Programme, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: abubakara@who.int., Hajjeh R; WHO Regional Office for the Eastern Mediterranean Region, Cairo, Egypt. Electronic address: hajjehr@who.int., Hutin YJ; Department of Communicable Diseases and Universal Health Coverage, WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. Electronic address: hutiny@who.int.

Publikováno v: Vaccine [Vaccine] 2024 Jun 20; Vol. 42 (17), pp. 3744-3750. Date of Electronic Publication: 2024 May 25.

Impact of COVID-19 pandemic on Measles surveillance in Pakistan.

Autor: Rana MS; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan. Electronic address: ranavirologist@gmail.com., Usman M; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Alam MM; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Mere MO; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Ikram A; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Zaidi SSZ; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Salman M; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Sharif S; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Umair M; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Khurshid A; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan., Mujtaba G; Department of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.

Publikováno v: The Journal of infection [J Infect] 2021 Mar; Vol. 82 (3), pp. 414-451. Date of Electronic Publication: 2020 Oct 08.

Progress Toward Measles Elimination - Pakistan, 2000-2018.

Autor: Mere MO, Goodson JL, Chandio AK, Rana MS, Hasan Q, Teleb N, Alexander JP Jr

Publikováno v: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Jun 07; Vol. 68 (22), pp. 505-510. Date of Electronic Publication: 2019 Jun 07.